JPH02205773A - Hematoxylin staining solution - Google Patents
Hematoxylin staining solutionInfo
- Publication number
- JPH02205773A JPH02205773A JP2522889A JP2522889A JPH02205773A JP H02205773 A JPH02205773 A JP H02205773A JP 2522889 A JP2522889 A JP 2522889A JP 2522889 A JP2522889 A JP 2522889A JP H02205773 A JPH02205773 A JP H02205773A
- Authority
- JP
- Japan
- Prior art keywords
- staining
- amount
- hematoxylin
- pref
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 239000012192 staining solution Substances 0.000 title claims abstract description 15
- 239000007800 oxidant agent Substances 0.000 claims abstract description 7
- 239000003755 preservative agent Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 238000010186 staining Methods 0.000 abstract description 10
- 239000000243 solution Substances 0.000 abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 4
- 230000003405 preventing effect Effects 0.000 abstract description 4
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 abstract description 3
- 235000011187 glycerol Nutrition 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 abstract 3
- 238000004062 sedimentation Methods 0.000 abstract 2
- 238000004321 preservation Methods 0.000 abstract 1
- 235000009518 sodium iodide Nutrition 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 238000012758 nuclear staining Methods 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- FQLQNUZHYYPPBT-UHFFFAOYSA-N potassium;azane Chemical compound N.[K+] FQLQNUZHYYPPBT-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- ZIQRIAYNHAKDDU-UHFFFAOYSA-N sodium;hydroiodide Chemical compound [Na].I ZIQRIAYNHAKDDU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
〔技術分野〕
本発明は新規なヘマトキシリン染色液に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION [Technical Field] The present invention relates to a novel hematoxylin staining solution.
一般に生体から採取された検体を組織検査に供するに当
ってはまずその組繊細胞をできるだけ変化させないよう
に適当な固定液に一定時間浸漬してこれを固定する。つ
いで包埋器に装入してパラフィンで包埋し、これをミク
ロトームにより一定厚みに薄く切る。えられた切片を染
色液につけて染色したのちガラス片にのせて標本としこ
れを検査に供する。Generally, when a specimen collected from a living body is subjected to a histological examination, the tissue cells are first fixed by immersing them in a suitable fixative for a certain period of time so as not to change them as much as possible. Then, it is placed in an embedding device and embedded in paraffin, and then cut into thin slices of a certain thickness using a microtome. The obtained section is stained by soaking it in a staining solution, and then placed on a piece of glass to make a specimen, which is then used for examination.
この組織標本をつくる際の染色液としてはヘマトキシリ
ン染色液が最も多く用いられている。この染色液による
ときは一般に核はブルーに染色され、細胞質や繊維と明
瞭に区別することができる。Hematoxylin staining solution is most often used as a staining solution when preparing this tissue specimen. When using this stain, the nucleus is generally stained blue and can be clearly distinguished from the cytoplasm and fibers.
この染色液としては核を濃く明瞭に染色する核染能力、
それと同時に核以外のものを同時に染めてしまわない共
染防止性、更に沈澱を生ずることなく長く保存使用しう
る保存性が夫々良好なことが要求されている。更に従来
は一般に5〜8μmの厚みの切片の標本で検査していた
が近年情報量の増大をめざして更に薄く約2〜3μm程
度にして検査するようになってきたが、このような薄い
切片にもよく染色しうろことも要求されている。This staining solution has the ability to stain nuclei darkly and clearly.
At the same time, it is required to have good co-staining prevention properties that prevent things other than the nucleus from being dyed at the same time, and also to have good preservability so that it can be stored and used for a long time without forming a precipitate. Furthermore, in the past, specimens were generally examined using sections with a thickness of 5 to 8 μm, but in recent years, with the aim of increasing the amount of information, examinations have begun to be made even thinner, approximately 2 to 3 μm. Well-dyed scales are also required.
このヘマトキシリン染色液としてはかなり以前から基本
的組成は変らないが数種のものが提供されている。それ
らの組成をまとめて示せば次の表1のとおりである。Several types of hematoxylin staining solutions have been available for quite some time, although the basic composition has not changed. Their compositions are summarized in Table 1 below.
これらの各染色液には夫々一長一短がありたとえばマイ
ヤーやカラッツィの液では4〜5μmの切片の場合では
短時間でよく染まるが、3μmの切片では30分以上の
染色時間を必要としいずれも次第に使用されなくなって
きた。又ハリスの液では全体的に濃く、鮮かに染まるが
水銀を用いる点に難点があり、又2倍力ラッツィ液とと
もに保存中に沈澱が生じてくるのでこれも実用的といい
難い。又ギル液も3μm切片には力が不足であり、3μ
m用にはほとんど使われていない。Each of these staining solutions has its own advantages and disadvantages; for example, Mayer's and Carazzi's solutions stain 4-5 μm sections well in a short time, but 3-μm sections require staining time of 30 minutes or more, and each solution is used gradually. This is no longer the case. In addition, Harris's solution produces a deep and vivid stain overall, but it has the disadvantage of using mercury, and also, along with double-strength Latzi's solution, precipitates form during storage, so this is also not practical. Also, Gill's solution is not strong enough for 3μm sections;
It is hardly used for m.
かくて、本発明は上記のような難点を解決して核染能力
、共染防止性と保存性にすぐれ、特に2〜3μmの薄い
切片の染色に良好に用いつるヘマトキシリン染色液を提
供することを目的とするものである。Thus, the present invention solves the above-mentioned difficulties and provides a hematoxylin staining solution that has excellent nuclear staining ability, anti-co-staining properties, and storage stability, and is particularly suitable for staining thin sections of 2 to 3 μm. The purpose is to
本発明者の多くの実験、研究によればこのような目的は
、重量比でヘマトキシリン0.2〜0.8%、媒染剤7
〜15%、酸化剤0,04〜0.06%、保存剤10〜
30%、有機酸又は無機酸0〜2.0%、残り水とから
なる新しいヘマトキシリン染色液によって達成されるこ
とが見出されたのである。According to many experiments and studies by the present inventor, this purpose was achieved by using a weight ratio of 0.2 to 0.8% hematoxylin and 7% mordant.
~15%, oxidizing agent 0.04~0.06%, preservative 10~
It has been found that this can be achieved with a new hematoxylin staining solution consisting of 30% organic or inorganic acid, 0-2.0% organic acid or inorganic acid, and the balance water.
本発明について更に詳細に説明する。尚本発明において
%は重量%を意味する。The present invention will be explained in more detail. In the present invention, % means weight %.
まずヘマトキシリンは0.2〜0.8%の範囲の量用い
られ、特に核染能力から云えば0.3%前後が好ましい
。又媒染剤としてはアンモニウム明パン、カリ明パンも
用いるが、これらは難溶性であり、本発明では易溶性の
硫酸アルミニウムが好んで用いられる。この媒染剤は7
〜15%、特に9〜12%用いるのが望ましく、その巾
約10.5%用いるのが最も望ましい。更にヘマトキシ
リン液を酸性にして染色させるために、酸化剤が0,0
4〜0.06%の量用いられる。酸化剤としてはヨー素
膜ナトリウムがもっとも実用的によく用いられるが、こ
の殊遇酸化水素(オキシフル)や過マンガン酸カリウム
も用いることができる。First, hematoxylin is used in an amount in the range of 0.2 to 0.8%, and in particular, from the viewpoint of nuclear staining ability, around 0.3% is preferable. Although ammonium ammonium and potassium ammonium are also used as mordants, they are poorly soluble, and in the present invention, readily soluble aluminum sulfate is preferably used. This mordant is 7
It is desirable to use ~15%, especially 9-12%, and most preferably to use a width of about 10.5%. Furthermore, in order to acidify the hematoxylin solution and dye it, an oxidizing agent of 0,0
Amounts of 4-0.06% are used. As the oxidizing agent, sodium iodine membrane is most often used practically, but hydrogen oxide (oxyflu) and potassium permanganate can also be used.
更に液の保存時に浮遊物が沈澱するのを防止するために
保存剤が10〜30%、好ましくは15〜25%の量用
いられる。この保存剤乃至沈澱防止剤としてはグリセリ
ン、抱水クロラール、エチレングリコール等を用いるこ
とができる。又更に酢酸、クエン酸等の有機酸や塩酸等
の無機酸等を0〜2.0%、好ましくは0.5〜1,5
%の量用いることができる。この酸や上記媒染剤を上記
よりも多く用いると共染をよく防止しうるが、全体の染
色性が劣化してきて好ましくない。Furthermore, a preservative is used in an amount of 10 to 30%, preferably 15 to 25%, to prevent floating substances from settling during storage of the liquid. As the preservative or anti-settling agent, glycerin, chloral hydrate, ethylene glycol, etc. can be used. Furthermore, organic acids such as acetic acid and citric acid and inorganic acids such as hydrochloric acid are added in an amount of 0 to 2.0%, preferably 0.5 to 1.5%.
% can be used. If this acid or the above-mentioned mordant is used in a larger amount than above, co-dyeing can be effectively prevented, but the overall dyeability deteriorates, which is not preferable.
今、これらの各化合物を種々の量用いて各種のヘマトキ
シリン染色液をつくり、特にその保存性を試験した結果
を示せば次の表2のとおりであった。Various hematoxylin staining solutions were prepared using various amounts of each of these compounds, and the preservability of the solutions was tested. The results are shown in Table 2 below.
表2から明らかなように本発明による染色液のもっとも
好ましい実施例は次のとおりである。As is clear from Table 2, the most preferred examples of the staining solution according to the present invention are as follows.
ヘマトキシリン 3.0g
水 ° 約700g硫酸アル
ミニウム 105g
ヨウ素酸ナトリウム 0.6g
グリセリン 200g
氷酢酸 5〜15゜
水を加えて 1,000ccこの液は次のよ
うな特徴を有している。Hematoxylin 3.0g Water Approximately 700g Aluminum sulfate 105g Sodium iodate 0.6g Glycerin 200g Glacial acetic acid 5-15° Add water to 1,000cc This liquid has the following characteristics.
1) 2〜3μm切片では10分程度で必要にして十
分な核染ができること。1) For 2-3 μm sections, sufficient nuclear staining can be achieved in about 10 minutes.
2)共染が少なく核染後の分別が不要なこと。2) There is little co-staining and no sorting is required after nuclear staining.
8)保存性がよく、製作後20週を越えても浮遊物は生
ぜず、染色性にほとんど変化が見られないこと。8) It has good storage stability, with no floating matter occurring even after 20 weeks after production, and almost no change in dyeability.
これらの特徴は、■)、2)、3)の各項目につき従来
広く採用されている処方に比べて優れていることであり
、これを仮に5段階評価で表せば、はぼ次の表3の如く
なる。These characteristics are that they are superior to conventionally widely adopted prescriptions in each of the items (■), 2), and 3). It will be like this.
表
マイヤ カラッ ハリス 2倍カラ ギ ル 本発明ラ
イ ツツイ
核染能力 115415
共染防止性 442 4 25保存性 44
1 3 25
〔発明の効果〕
上記のところから明らかなように、本発明のヘマトキシ
リン染色液によるときは2〜3μmの薄い切片を短時間
によく染色しうるとともに、核をよく染め、共染を防止
でき、長期間保存しても沈澱を生じることがない等の効
果を有するので誠に実用的である。Omotemiya Kara Harris 2x Kara Gil Present invention light Tsutsui nuclear staining ability 115415 Co-contamination prevention property 442 4 25 Preservability 44
1 3 25 [Effects of the Invention] As is clear from the above, when using the hematoxylin staining solution of the present invention, thin sections of 2 to 3 μm can be well stained in a short time, and the nucleus is well stained and co-staining is prevented. It is very practical because it has the effect of preventing precipitation and preventing precipitation even when stored for a long period of time.
Claims (1)
15%、酸化剤0.04〜0.06%、保存剤10〜3
0%、有機酸又は無機酸0〜2.0%、残余水からなる
ヘマトキシリン染色液。Hematoxylin 0.2-0.8% by weight, mordant 7-
15%, oxidizing agent 0.04-0.06%, preservative 10-3
A hematoxylin staining solution consisting of 0% organic acid or inorganic acid 0-2.0% and residual water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2522889A JP2702211B2 (en) | 1989-02-03 | 1989-02-03 | Hematoxylin staining solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2522889A JP2702211B2 (en) | 1989-02-03 | 1989-02-03 | Hematoxylin staining solution |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02205773A true JPH02205773A (en) | 1990-08-15 |
JP2702211B2 JP2702211B2 (en) | 1998-01-21 |
Family
ID=12160113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2522889A Expired - Lifetime JP2702211B2 (en) | 1989-02-03 | 1989-02-03 | Hematoxylin staining solution |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2702211B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010521678A (en) * | 2007-03-15 | 2010-06-24 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | Stabilized hematoxylin |
JP2014059282A (en) * | 2012-09-18 | 2014-04-03 | Kikuo Wakamatsu | Antimicrobial hematoxylin solution and expanded antimicrobial hematoxylin solution |
JP2015505062A (en) * | 2012-01-26 | 2015-02-16 | ライカ バイオシステムズ リッチモンド インコーポレイテッドLeica Biosystems Richmond, Inc. | Methods and compositions for hematoxylin and eosin staining |
CN108414328A (en) * | 2018-04-04 | 2018-08-17 | 南京烁朴生物科技有限公司 | A kind of modified form hematoxylin dyeing liquor reagent, preparation method and colouring method |
CN110907257A (en) * | 2019-12-24 | 2020-03-24 | 苏州堪赛尔生物技术有限公司 | Hematoxylin staining solution and preparation method and application method thereof |
-
1989
- 1989-02-03 JP JP2522889A patent/JP2702211B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010521678A (en) * | 2007-03-15 | 2010-06-24 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | Stabilized hematoxylin |
US8263361B2 (en) | 2007-03-15 | 2012-09-11 | Ventana Medical Systems, Inc. | Stabilized hematoxylin |
US8551731B2 (en) | 2007-03-15 | 2013-10-08 | Ventana Medical Systems, Inc. | Stabilized hematoxylin |
JP2015505062A (en) * | 2012-01-26 | 2015-02-16 | ライカ バイオシステムズ リッチモンド インコーポレイテッドLeica Biosystems Richmond, Inc. | Methods and compositions for hematoxylin and eosin staining |
JP2014059282A (en) * | 2012-09-18 | 2014-04-03 | Kikuo Wakamatsu | Antimicrobial hematoxylin solution and expanded antimicrobial hematoxylin solution |
CN108414328A (en) * | 2018-04-04 | 2018-08-17 | 南京烁朴生物科技有限公司 | A kind of modified form hematoxylin dyeing liquor reagent, preparation method and colouring method |
CN110907257A (en) * | 2019-12-24 | 2020-03-24 | 苏州堪赛尔生物技术有限公司 | Hematoxylin staining solution and preparation method and application method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2702211B2 (en) | 1998-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ehrlich et al. | Amyloidosis of the islets of Langerhans: a restudy of islet hyalin in diabetic and nondiabetic individuals | |
Kiernan | Histological and histochemical methods | |
Wattendorff et al. | Studies on the ultrastructure and histochemistry of plant cuticles: the cuticular membrane of Agave americana L. in situ | |
Mohr et al. | A method of preparing highly vacuolated, senescent, or damaged plant tissue for ultrastructural study | |
Goodey | Two methods for staining nematodes in plant tissues | |
Gray | The botanical text-book | |
Samour et al. | Normal haematology of free-living green sea turtles (Chelonia mydas) from the United Arab Emirates | |
Vacelet et al. | Virus-like particles in cells of the sponge Verongia cavernicola (Demospongiae, Dictyoceratida) and accompanying tissues changes | |
JPH02205773A (en) | Hematoxylin staining solution | |
Broda et al. | The weight of the chromophore carrier in the visual purple molecule | |
Preece | A staining method for the study of Apple scab infections. | |
Jensen et al. | Shrinkage in preparatory steps for SEM: A study on rabbit corneal endothelium | |
Stewart | The permeability of the Arbacia egg to nonelectrolytes | |
Rossomacha et al. | Simple methods for staining chitosan in biotechnological applications | |
Almén et al. | Effects of Metrizamide on Silver Staining of Aortic Endothelium: A Comparison with Metrizoate Media in Rats | |
CN113432946A (en) | Aqueous dewaxing liquid and dewaxing method thereof | |
JPH0331388B2 (en) | ||
US3440317A (en) | Cell coloring process and composition for cytological examination | |
Swan et al. | Osmotic regulation in isolated liver and kidney slices | |
Nebel | Chlorazol black E as an aceto-carmine auxiliary stain | |
Mossman | The dioxan technic | |
Lillie et al. | Black periodic and black Bauer methods for tissue polysaccharides | |
Kelly | An evaluation of the metachromasy of anionic dyes. I. Visual observations on tissue sections | |
Eggert et al. | Staining of demineralized cartilage: I. Alcoholic versus aqueous demineralization at neutral and acidic pH | |
Spurr | Polyvinyl alcohol with cadmium iodide and fructose as an aqueous mounting medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081003 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081003 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091003 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091003 Year of fee payment: 12 |